APPLICATIONS PUBLISHED 29 DECEMBER 2004
Published: 15-Dec-2005
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Citalopram for the treatment of elevated blood pressure
Egis Gyogtszergyar 1490049*
Methods for Alzheimer's disease treatment and cognitive enhancement
Blanchette Rockefeller Neurosciences Institute 1490050*
Use of topoisomerase inhibitors and heat shock protein 90 inhibitors for use in chemotherapy
The University of Liverpool 1490051*
Device for the transdermal administration of a rotigonine base
Schwarz Pharma 1490052*
Combined therapy against tumours comprising substituted acryloyl distamycin derivatives and radiotherapy
Pharmacia Italia 1490053*
Hemiasterlin derivatives and uses thereof in the treatment of cancer
Eisai Co 1490054*
Use of selective EP4 receptor agonists for the treatment of liver failure, loss of potency of the ductus arteriosis glaucoma or ocular hypertension
Pfizer Products 1490055*
N'-4-(2-imino-pyrrolidin-1-yl)phenyl)-acetamide and corresponding piperidine derivatives as factor XA inhibitors for the treatment of thrombo-embolic diseases
Merck 1490056*
Method for treating cognitive disorders
Axonyx; The Government of the United States of America as represented by the Secretary, the Department of Health and Human Services 1490057*
Peroxisome proliferator activated receptor modulators
Eli Lilly 1490058*
Parenteral, intravenous and oral administration of oxazolidinones for treating diabetic foot infections
Pharmacia & upjohn 1490059*
Antidiabetic agents
Warner-Lambert 1490060*
Pharmaceutical compsns comprising a benzofuran derivative and their use for the treatment of attention deficit disorder
Merck Sharp & Dohme 1490061*
Glucocorticoid mimetics, methods of making them, pharmaceutical compsns, and uses thereof
Boehringer Ingelheim 1490062*
Use of proton pump inhibitors for the treatment of noncardiac chest pain
Altana Pharma 1490063*
Substituted pyridinones as modulators of P38 MAP kinases
Pharmacia 1490064*
Benzylimidazolyl substituted 2-quinolinone and quinolinone derivatives for use as farnesyl transferase inhibitors
Janssen Pharmaceutica 1490065*
Use of ranolazine for the preparation of a medicament for the treatment of arrhythmias
CV Therapeutics 1490066*
Use of tyrosine kinase inhibitors for treating substance use disorders
AB Science 1490067*
Powder compsn comprising zaleplon of defined particle size distribution and pharmaceutical products made therefrom
Biogal Gyogyszergyar 1490068*
Alpha AED and beta AED regulation of nuclear transcription, gene regulation, and/or gene expression
Loria, Roger 1490069*
Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
Wyeth 1490070*
Therapeutic methods and uses of sapogenins and their derivatives
Phytopharm 1490071*
Novel therapeutical use of agonist ligands specific to G2A receptor
Biosynergen 1490072*
Serotonin and catecholamine system segment optimisation technology
Hinz, Martin 1490073*
Mixed-cell gene therapy
Tissuegene 1490074*
Bioadhesive directed somatic cell therapy
Tissuegene 1490075*
Novel metabolic targets and markers
Lipomics Technologies 1490076*
A photoprotective orally administrable compsn for skin
Societe des Produits Nestle 1490077*
Hepatocurative effect of emblica officinalis on hepatoxicity related to cytochrome P-450
Council of Scientific and Industrial Research, New Delhi 1490078*
A compsn for treating gastric ulcer and a process for preparing the same
Council for Scientific and Industrial Research, New Delhi 1490079*
A process for the extraction of anthocyanins from black rice and compsn thereof
Forbes Medi-Tech 1490080*
Isolation of a dual Cox-2 and 5-lipoxygenase inhibitor from acacia
Unigen Pharmaceuticals 1490081*
Compsns and methods for preventing and treating cancer via modulating UBE1L, ISG15 and/or UBP43
Trustees of Dartmouth College; University of Maryland, Baltimore 1490082*
Microgel particles for the delivery of bioactive materials
The Regents of the University of California 1490083*
Compsns and methods for regulating thyroid hormone metabolism and cholesterol and lipid metabolism via the nuclear receptor CAR
SmithKline Beecham 1490084*
FC receptor homologue, reagents, and uses thereof
UAB Research Foundation 1490085*
Use of an organ-specific self-pathogen for treatment of a non-autoimmune disease of said organ
Yeda Research and Development Company 1490086*
Self-assembling-peptide-based structures and processes for controlling the self-assembly of such structures
Emory University 1490087*
Dendritic cell nodes
Sciperio 1490088*
Peptides selectively lethal to malignant and transformed mammalian cells
The Research Foundation of State University of New York 1490089*
Active agent delivery systems and methods for protecting and administering active agents
New River Pharmaceuticals 1490090*
Enhancement of endogenous gonadotropin production
TAP Pharmaceutical Products 1490091*
Cosmetic or pharmaceutical compsn containing peptides
Societe d'Extraction des Principes Actifs 1490092*
Methods and compsns for the treatment of ischaemia
Chiron Corp 1490093*
Antibody fusion proteins: effective adjuvants of protein vaccination
The Regents of the University of California 1490094*
Stable pharmaceutical compsn containing factor VIII
Societe de Conseils de Recherches et d'Applications Scientifiques 1490095*
Use of hydrogen peroxide producing enzyme for treatment of otitis media
Tano, Krister 1490096*
Use of botulinum toxin for treating cardiovascular diseases
Allergan 1490097*
Chemotherapeutic agents as anti-cancer vaccine adjuvants and therapeutic methods thereof
Technologies Biolactis 1490098*
Human monoclonal antibodies to influenza M2 protein and methods of making and using the same
Kirin Beer KK 1490099*
Combined DNA/protein vaccine compsns
Bremmtag Biosector 1490100*
Methods of inducing immune induction involving MDA-7
Board of Regents The University of Texas System 1490101*
Process for manufacturing pharmaceutical compsn comprises of mycobacterium W in the treatment of asthma (obstructive lung disease)
Modi, Rajiv; Khamar, Bakulesh 1490103*
Protein-based streptococcus pneumoniae vaccines
Bun-Gurion University of the Negev Research and Development Authority 1490104*
Multiple and multivalent DNA vaccines in ovo
Schweitzer Chemical Corp 1490105*
Use of a lipopeptide or lipoprotein as an adjuvant in therapeutic or prophylactic vaccinations
GBF Gesellschaft fuer Biotechnische Forschung 1490106*
Modulating angiogenesis
University of Florida 1490107*
DRG-11 responsive (dragon) gene family
The General Hospital Corp 1490108*
EGFR ligands and methods of use
The Penn State Research Foundation 1490109*
Anti-alpha V beta 6 antibodies
Biogen Idec; The Regents of the University of California 1490110*
EDG-receptor agonists for the treatment of hypertension
Solvay Pharmaceuticals 1490111*
Method and agent for producing therapeutically active blood compsns
Orthogen AG 1490112*
RAAV vector compsns and methods for the treatment of choroidal neovascularisation
University of Florida Research Foundation 1490113*
Pendant fatty acid imaging agents
Biostream 1490114*
Drug delivery particle
Boston Scientific 1490121*
Glucocorticoid mimetics, methods of making them, pharm,aceutical compsns, and uses thereof
Boehringer Ingelheim Pharmaceuticals 1490317*
Method for producing 3-hydroxy-2-methylbenzoic acid
Bayer Chemicals 1490319*
Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors
Teva Pharmaceutical Industries 1490324*
Manufacture of phenyl ethylamine compounds, in particular venlafaxine
Nicholas Piramal India 1490325*
Compsns and methods for inhibition of phospholipase A2 mediated inflammation
The Regents of the University of California 1490328*
Method of synthesising 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol
Wisonsin Alumni Research Foundation 1490332*
New atorvastatin salts and pharmaceutical compsns containing them
Richter Gedeon Vegyeszeti Gyar 1490333*
Phthalimido derivatives as inhibitors of monoamine oxidase
F Hoffmann-La Roche 1490334*
Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
Merck 1490335*
Piperidine or 8-aza-bicyclo(3.2.1)oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially CCR5)
AstraZeneca 1490336*
Use of an alpha2-adrenoreceptor antagonist for CNS-related diseases
Orion Corp 1490338*
Novel chalcone derivatives and uses thereof
The Walter and Eliza Hall Institute of Medical Research 1490339*
